List of bibliographic references
Number of relevant bibliographic references: 9.
List of associated KwdEn.i
Nombre de documents | Descripteur |
6 | Humans |
5 | Adult |
5 | Female |
5 | Male |
5 | Middle Aged |
3 | Disease-Free Survival |
2 | Adolescent |
2 | Aged |
2 | Bone Marrow Transplantation |
2 | Hematopoietic Stem Cell Transplantation (methods) |
2 | Retrospective Studies |
2 | Siblings |
2 | Survival Rate |
2 | Transplantation Conditioning |
2 | Transplantation Conditioning (methods) |
2 | Transplantation, Homologous |
1 | Administration, Intravenous |
1 | Administration, Oral |
1 | Age Factors |
1 | Allografts |
1 | Anemia, Aplastic (mortality) |
1 | Anemia, Aplastic (therapy) |
1 | Animals |
1 | Antifungal Agents (economics) |
1 | Antifungal Agents (therapeutic use) |
1 | Busulfan (administration & dosage) |
1 | Child |
1 | Child, Preschool |
1 | Cost-Benefit Analysis |
1 | Cyclophosphamide (administration & dosage) |
1 | Decision Support Techniques |
1 | Fluconazole (economics) |
1 | Fluconazole (therapeutic use) |
1 | Follow-Up Studies |
1 | Graft Rejection (mortality) |
1 | Guinea Pigs |
1 | Hematopoietic Stem Cell Transplantation |
1 | Infant |
1 | Invasive Fungal Infections (economics) |
1 | Invasive Fungal Infections (ethnology) |
1 | Invasive Fungal Infections (microbiology) |
1 | Invasive Fungal Infections (prevention & control) |
1 | Itraconazole (economics) |
1 | Itraconazole (therapeutic use) |
1 | Japan |
1 | Kaplan-Meier Estimate |
1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (mortality) |
1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy) |
1 | Lymphoma, Non-Hodgkin (therapy) |
1 | Myeloablative Agonists (administration & dosage) |
1 | Neoplasm, Residual |
1 | Peripheral Blood Stem Cell Transplantation |
1 | Philadelphia Chromosome |
1 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (epidemiology) |
1 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (therapy) |
1 | Precursor Cell Lymphoblastic Leukemia-Lymphoma (pathology) |
1 | Precursor Cell Lymphoblastic Leukemia-Lymphoma (surgery) |
1 | Proportional Hazards Models |
1 | Protein-Tyrosine Kinases (antagonists & inhibitors) |
1 | Recurrence |
1 | Remission Induction |
1 | Socioeconomic Factors |
1 | Spain |
1 | Survival Analysis |
1 | Triazoles (economics) |
1 | Triazoles (therapeutic use) |
1 | Voriconazole (therapeutic use) |
1 | Whole-Body Irradiation |
1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "David I. Marks"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "David I. Marks" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= David I. Marks
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |